Amundi’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
Other funds holding ALDR
Amundi's ALDR Position: Q3 2018 in Review
Amundi sold out of Alder Biopharmaceuticals (ALDR) in Q3 2018, closing a stake of 123,900 shares — an estimated $1.96M sold.
Amundi first reported a position in ALDR in Q2 2015 and held it in 10 quarters. The position peaked at $49.5M in Q2 2015. 127 funds tracked by Wall St. Rank hold ALDR as of Q3 2018.
- Amundi reported no remaining Alder Biopharmaceuticals position as of Q3 2018 after selling out during the quarter.
- Amundi sold 123,900 Alder Biopharmaceuticals shares in Q3 2018, an estimated $1.96M.
- Amundi first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 10 quarters.
- Amundi's Alder Biopharmaceuticals position peaked at $49.5M in Q2 2015.
- 127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2018.
Based on Amundi's 13F filing for Q3 2018, filed 14 Nov 2018.